CompoSecure, Inc. (NASDAQ:CMPO – Get Rating) major shareholder Donald G. Basile sold 183,002 shares of the company's stock in a transaction dated Monday, January 23rd. The shares were sold at an average price of $5.88, for a total transaction of $1,076,051.76. Following the sale, the insider now directly owns 1,708,933 shares of the company's stock, valued at $10,048,526.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
CompoSecure Trading Up 0.7 %
NASDAQ:CMPO traded up $0.04 on Wednesday, hitting $6.04. 91,838 shares of the company's stock traded hands, compared to its average volume of 213,527. The firm has a 50-day moving average price of $4.95 and a 200-day moving average price of $5.30. The company has a market cap of $461.13 million, a PE ratio of 2.73 and a beta of 0.67. CompoSecure, Inc. has a 1 year low of $4.26 and a 1 year high of $9.09.
Get
CompoSecure alerts:
CompoSecure (NASDAQ:CMPO – Get Rating) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.04. The firm had revenue of $103.31 million for the quarter, compared to the consensus estimate of $98.39 million. CompoSecure had a net margin of 10.97% and a negative return on equity of 3.01%. On average, research analysts forecast that CompoSecure, Inc. will post 0.97 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. BTIG Research started coverage on shares of CompoSecure in a report on Tuesday, December 13th. They set a "buy" rating and a $9.00 price target on the stock. JPMorgan Chase & Co. started coverage on shares of CompoSecure in a research note on Tuesday, October 11th. They set an "overweight" rating and a $10.00 target price on the stock.
Hedge Funds Weigh In On CompoSecure
Several institutional investors and hedge funds have recently modified their holdings of CMPO. Bleichroeder LP raised its holdings in shares of CompoSecure by 23.9% during the third quarter. Bleichroeder LP now owns 2,933,344 shares of the company's stock worth $14,696,000 after acquiring an additional 566,355 shares in the last quarter. Tikvah Management LLC increased its position in CompoSecure by 0.4% in the 3rd quarter. Tikvah Management LLC now owns 904,365 shares of the company's stock worth $4,531,000 after purchasing an additional 3,649 shares during the last quarter. BlackRock Inc. raised its stake in shares of CompoSecure by 1.4% during the 3rd quarter. BlackRock Inc. now owns 428,346 shares of the company's stock worth $2,146,000 after purchasing an additional 5,760 shares in the last quarter. Polar Asset Management Partners Inc. acquired a new stake in shares of CompoSecure during the 1st quarter valued at about $1,548,000. Finally, Vanguard Group Inc. bought a new stake in shares of CompoSecure in the 1st quarter valued at approximately $1,506,000. 31.77% of the stock is currently owned by hedge funds and other institutional investors.
CompoSecure Company Profile
(Get Rating)
CompoSecure, Inc manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which comprise the Arculus Key card Cold Storage hardware device and companion Arculus Wallet mobile App to keep the Private Key in the Arculus Key card highly secure and store cryptocurrency and digital assets.
Featured Stories
- Get a free copy of the StockNews.com research report on CompoSecure (CMPO)
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for CompoSecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompoSecure and related companies with MarketBeat.com's FREE daily email newsletter.
